Univar Inc. is a global distributor of chemicals and innovative services. The company serves in coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries.
Univar is executing several cost-saving programs in an attempt to drive productivity and operational excellence and grow organically. The company also looks to strengthen its balance sheet by reducing debt.
Let’s have a quick look at the chemical company’s third-quarter 2017 release.
Estimate Trend & Surprise History
Investors should note that the earnings estimate for Univar for the third quarter has been going down over the past month. Univar has delivered an average positive surprise of 4% over the trailing four quarters.
Univar Inc. Price and EPS Surprise
Earnings
Univar’s adjusted earnings for the quarter were 36 cents, topping the Zacks Consensus Estimate of 23 cents.
Revenues
Univar recorded net sales of $2,048.7 million, up roughly 2.5% year over year. It surpassed the Zacks Consensus Estimate of $1,949 million.
Key Stats/Developments to Note
The company expects adverse impacts of hurricanes to continue in the fourth quarter. For fourth-quarter 2017, it expects adjusted EBITDA growth of mid-single digits from previous year's figure of $134.5 million.
Zacks Rank
Currently, Univar has a Zacks Rank #4 (Sell).
Market Reaction
Univar’s shares were inactive in premarket trading. It would be interesting to see how the market reacts to the results during the trading session today.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Image: Bigstock
Univar's (UNVR) Q3 Earnings & Sales Beat Estimates
Univar Inc. is a global distributor of chemicals and innovative services. The company serves in coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries.
Univar is executing several cost-saving programs in an attempt to drive productivity and operational excellence and grow organically. The company also looks to strengthen its balance sheet by reducing debt.
Let’s have a quick look at the chemical company’s third-quarter 2017 release.
Estimate Trend & Surprise History
Investors should note that the earnings estimate for Univar for the third quarter has been going down over the past month. Univar has delivered an average positive surprise of 4% over the trailing four quarters.
Univar Inc. Price and EPS Surprise
Univar Inc. Price and EPS Surprise | Univar Inc. Quote
Earnings
Univar’s adjusted earnings for the quarter were 36 cents, topping the Zacks Consensus Estimate of 23 cents.
Revenues
Univar recorded net sales of $2,048.7 million, up roughly 2.5% year over year. It surpassed the Zacks Consensus Estimate of $1,949 million.
Key Stats/Developments to Note
The company expects adverse impacts of hurricanes to continue in the fourth quarter. For fourth-quarter 2017, it expects adjusted EBITDA growth of mid-single digits from previous year's figure of $134.5 million.
Zacks Rank
Currently, Univar has a Zacks Rank #4 (Sell).
Market Reaction
Univar’s shares were inactive in premarket trading. It would be interesting to see how the market reacts to the results during the trading session today.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>